Neuromodulation market was valued at USD 2,480.2 million in 2020 and is projected to reach USD 4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 to 2030| Valuates Reports.
Epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease are the most common neurological disorder, which affect the central and peripheral nervous system. These neurological disorders are caused by genetic disorders, congenital abnormalities or disorders, infections, lifestyle or environmental health problems, including malnutrition, and brain injury, spinal cord injury or nerve injury. Bacterial, viral, and fungal infections also responsible for neurological disorders.
Get a Free sample: https://reports.valuates.com/request/sample/ALLI-Auto-4T60/Neuromodulation_Market_by_Technology_Deep_Brain_Stimulation_Sacral_Nerve_Stimulation_Vagus_Nerve_Stimulation_Spinal_Cord_Stimulation_Application_Chronic_Pain_Management_Failed_back_syndrome_Epilepsy_Tremor_Incontinence_Depression_Dystonia_Gastroparesis_Parkinsons_disease_Obsessive_Compulsive_Disorder_Migraine_and_Biomaterial_Metallic_Polymeric_Ceramic_Global_Opportunity_Analysis_and_Industry_Forecast_2014_2022
The increase in prevalence of neurological diseases globally drives the growth of the neuromodulation market. For instance, according to the Epilepsy Action organization, which is the British charity providing information for population with epilepsy, in February 2022, around 600,000 population are diagnosed with epilepsy, in UK, which is around one in every 100 population. In addition, increase in geriatric population propels the growth of neuromodulation market. The increase in R&D activities in the pharmaceutical sector and rise in number of clinical trials in the neuromodulation devices by manufacturers and researchers also contribute in the growth of market. Furthermore, surge in awareness for use of neuromodulation devices further boosts the market growth. The rise in number of hospitals and well-developed healthcare infrastructure further contributes in market growth.
In addition, increase in advancement in technology for neuromodulation devices and rise in product launch in the field of neuromodulation devices contribute in the growth of the neuromodulation market. However, the high cost of neuromodulation devices are expected to limit the growth of market.
Global Neuromodulation Market Segmentation
The neuromodulation market is segmented on the basis of technology, application, biomaterial, and region. By technology, the market is mainly categorized into internal neuromodulation and external neuromodulation. By application, it is categorized in chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson disease, epilepsy, tremor, depression, and other applications. On the basis of biomaterial, it is divided into, metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Abbott, Aleva, Neurotherapeutics SA., Boston Scientific Corporation, LivaNova, Medtronic, MicroTransponder, Neuronetics, NeuroPace Inc., NeuroSigma, and Nevro Corporation.
View full Report:https://reports.valuates.com/market-reports/ALLI-Auto-4T60/neuromodulation
KEY BENEFITS FOR STAKEHOLDERS
• The report provides an in-depth analysis of the global neuromodulation market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global neuromodulation market growth.
Neuromodulation Market Segmentation
• Internal Neuromodulation
• External Neuromodulation
• Chronic Pain
• Urinary And Fecal Incontinence
• Failed Back Syndrome
• Parkinson Disease
• Other Applications
• Metallic Biomaterials
• Polymeric Biomaterials
• Ceramic Biomaterials
• North America
Key Market Players
• LivaNova PLC
• Nevro Corporation
• Bioventus Inc.
• NeuroPace Inc
• Boston Scientific Corporation
Inquire For Regional Reports: https://reports.valuates.com/request/regional/ALLI-Auto-4T60/Neuromodulation_Market_by_Technology_Deep_Brain_Stimulation_Sacral_Nerve_Stimulation_Vagus_Nerve_Stimulation_Spinal_Cord_Stimulation_Application_Chronic_Pain_Management_Failed_back_syndrome_Epilepsy_Tremor_Incontinence_Depression_Dystonia_Gastroparesis_Parkinsons_disease_Obsessive_Compulsive_Disorder_Migraine_and_Biomaterial_Metallic_Polymeric_Ceramic_Global_Opportunity_Analysis_and_Industry_Forecast_2014_2022
1. Deep Brain Stimulation System Market : https://reports.valuates.com/market-reports/QYRE-Auto-20Y3138/global-deep-brain-stimulation-system
2. Overactive Bladder Treatment Device Market : https://reports.valuates.com/market-reports/QYRE-Auto-33P11666/global-overactive-bladder-treatment-device
3. Medical RF Lesion Generator Market: https://reports.valuates.com/market-reports/QYRE-Auto-12D11466/global-medical-rf-lesion-generator
4. Radiofrequency Ablation Instrument Market: https://reports.valuates.com/market-reports/QYRE-Auto-19O7278/global-radiofrequency-ablation-instrument
5. Pain Management RF Lesion Generator Market : https://reports.valuates.com/market-reports/QYRE-Auto-31Z11171/global-pain-management-rf-lesion-generator
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137
Please reach us at firstname.lastname@example.org
Whitefield Main road,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuromodulation market was valued at USD 2,480.2 million in 2020 and is projected to reach USD 4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 to 2030| Valuates Reports. here
News-ID: 2746866 • Views: 489
More Releases from Valuates Reports
Commercial Distributed Energy Generation Market: Size, Share, Growth, Analysis, …
Global Commercial Distributed Energy Generation Market It is a variety of small, connected to the grid equipment power generation and energy storage technology and systems. It is a kind of decentralized power generation, which is the opposite of distributed power generation. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-0U6317/Global_Commercial_Distributed_Energy_Generation_Market_Size_Status_and_Forecast_2021_2027 The global Commercial Distributed Energy Generation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during
Avalanche Radar Market: Size, Share, Growth, Analysis, Key Players, Revenue, Gro …
Avalanche Radar Market According to new survey, global Avalanche Radar market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-14C15737/Global_Avalanche_Radar_Market_Research_Report_2023 Key manufacturers engaged in the Avalanche Radar industry include Geobrugg, Wyssen Avalanche, LB Foster, Hexagon and Recco, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022. For production bases,
Software-Defined Networking Market: Size, Share, Growth, Analysis, Key Players, …
Global Software-Defined Networking Market Software-defined networking (SDN) encompasses different types of network technology that are aimed at making the network as flexible and agile as the virtualized server of the modern data center. The primary goal of SDN is to allow engineers and network administrators to respond effectively to changing business requirements. In such a network, the network administrator can control traffic from a centralized control console without having to touch
Reactive Hot Melt Adhesives Market : Size, Share, Growth, Analysis, Key Players, …
Reactive Hot Melt Adhesives Market Size According to QYResearch's new survey, global Reactive Hot Melt Adhesives market is projected to reach US$ 2174.5 million in 2029, increasing from US$ 1319.9 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2029. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-14S7306/Global_Reactive_Hot_Melt_Adhesives_Market_Insights_Forecast_to_2028 Reactive Hot Melt Adhesives Market Reactive Hot Melt Adhesives refer to hot melt adhesives that undergo chemical cross-linking upon cooling and solidification, providing enhanced adhesion and
More Releases for Neuromodulation
Internal Neuromodulation Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Internal Neuromodulation market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report. This report is
Neuromodulation Devices Market 2022 | Detailed Report
The Neuromodulation Devices research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,
Neuromodulation Market Overview and Industry Outlook 2020
Global Neuromodulation Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Neuromodulation Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected
Neuromodulation Market Thriving Worldwide $11,717 Million By 2022
The global neuromodulation market size is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. The global neuromodulation devices market is estimated to reach $11,717 million by 2022. For More Info, Get PDF Sample : http://bit.ly/2BciOaa Neurological disorders such as epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease affect the central and peripheral nervous system. Bacterial, viral, and fungal infections
Global Neuromodulation Devices Market 2027: Comprehensive Report Study
Market Research Future published a research report on “Global Neuromodulation Devices Market Research Report- Forecast To 2027” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027. Global neuromodulation devices market Information, by types by Techniques Applications - Forecast to 2027 Globally the market for neuromodulation devices is increasing rapidly. The major factor that derives the growth of neuromodulation devices is the increasing development neuromodulation devices. Furthermore increasing demand
Sacral Neuromodulation Systems Market Outlook to 2025
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities. According to a study on neuromodulation devices and therapies, neuromodulation is a safe, effective, and long term treatment for chronic pain and movement disorders. Neuromodulation technology is gaining momentum